{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06309355",
            "orgStudyIdInfo": {
                "id": "YR001-A03"
            },
            "organization": {
                "fullName": "Hangzhou Yirui Pharmaceutical Technology Co., Ltd",
                "class": "INDUSTRY"
            },
            "briefTitle": "Topical YR001 Ointment in Adult With Mild to Moderate Atopic Dermatitis",
            "officialTitle": "A Randomized, Placebo-controlled, Double-blind, Multi Center, Phase IIa Trial Investigating the Safety, Tolerability, Pharmacokinetics and Efficacy of Topical Ointment YR001 in Adult Patients With Mild to Moderate Atopic Dermatitis",
            "therapeuticArea": [
                "Dermatology"
            ],
            "study": "topical-ointment-in-adult-with-mild-to-moderate-atopic-dermatitis"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-03",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-06-19",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-01-20",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-06-20",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-03-06",
            "studyFirstSubmitQcDate": "2024-03-06",
            "studyFirstPostDateStruct": {
                "date": "2024-03-13",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-06-24",
            "lastUpdatePostDateStruct": {
                "date": "2024-06-26",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Hangzhou Yirui Pharmaceutical Technology Co., Ltd",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This study is to evaluate the safety, tolerability, and pharmacokinetics of YR001 topical ointment in adult patients with mild to moderate atopic dermatitis"
        },
        "conditionsModule": {
            "conditions": [
                "Atopic Dermatitis"
            ],
            "keywords": [
                "YR001",
                "KV1.3"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "TRIPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 36,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Active dose",
                    "type": "EXPERIMENTAL",
                    "description": "The intervention is YR001 ointment on a range of body surface area for multiple topical administration",
                    "interventionNames": [
                        "Drug: YR001 ointment"
                    ]
                },
                {
                    "label": "Placebo dose",
                    "type": "EXPERIMENTAL",
                    "description": "The intervention is Placebo on a range of body surface area for multiple topical administration",
                    "interventionNames": [
                        "Other: Placebo"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "YR001 ointment",
                    "description": "The intervention is YR001 ointment on a range of body surface area for multiple topical administration",
                    "armGroupLabels": [
                        "Active dose"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "Placebo",
                    "description": "The intervention is Placebo on a range of body surface area for multiple topical administration",
                    "armGroupLabels": [
                        "Placebo dose"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "The primary endpoint will be safety. Specifically, the primary endpoint will be the incidence of treatment-related AEs (TRAEs) through Day 50.",
                    "description": "incidence of treatment related AEs (TRAEs)",
                    "timeFrame": "Day1-Day 50"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "all treatment-emergents AEs",
                    "description": "number, severity, causality, and outcome of all treatment-emergetns AEs (TEAEs)",
                    "timeFrame": "Day1-Day 50"
                },
                {
                    "measure": "Efficacy of YR001 Ointment",
                    "description": "Proportion of patients achieving ISGA 0 or 1 by visit",
                    "timeFrame": "Day1-Day50"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. Written informed consent obtained from the subject.\n2. Male or female subject is aged 18 or older.\n3. Subject has a weight of at least 50 kg and a body mass index (BMI) between 18.0 and 30.0 kg/m2, inclusive.\n4. An Investigator Static Global Assessment (ISGA) score of 2 (mild) to 3 (moderate) at screening and Baseline.\n\nExclusion Criteria:\n\n1. Pregnant or lactating women.\n2. Any skin tattoo, scar, cuts, bruises, or other skin damage, including excessive UV exposure, at the possible IP application sites.\n3. Patients who have a source of itch solely or significantly from untreatable areas (face, scalp, genitals, palms of hands or soles of feet).\n4. Have concomitant skin disease or infection (e.g., acne, impetigo) or presence of skin comorbidities in the skin areas to be dosed that may interfere with study assessments and treatment response.\n5. Participation in another interventional clinical trial (e.g. investigational drug, biological agent, or device) within 30 days or 5 half-lives of investigational agent (whichever is longer) before entering, or during the trial, or previous participation in this clinical trial.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Kevin Wei, Doctor",
                    "role": "CONTACT",
                    "phone": "+8615706771488",
                    "email": "kai.wei@yirui-pharma.com"
                },
                {
                    "name": "Lili Wu",
                    "role": "CONTACT",
                    "phone": "+8615706771488",
                    "email": "lili.wu@yirui-pharma.com"
                }
            ],
            "locations": [
                {
                    "facility": "DelRicht Research",
                    "status": "RECRUITING",
                    "city": "Baton Rouge",
                    "state": "Louisiana",
                    "zip": "70809",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Ira H Thorla, Doctor",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 30.45075,
                        "lon": -91.15455
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000003876",
                    "term": "Dermatitis, Atopic"
                },
                {
                    "id": "D000003872",
                    "term": "Dermatitis"
                },
                {
                    "id": "D000004485",
                    "term": "Eczema"
                }
            ],
            "ancestors": [
                {
                    "id": "D000012871",
                    "term": "Skin Diseases"
                },
                {
                    "id": "D000012873",
                    "term": "Skin Diseases, Genetic"
                },
                {
                    "id": "D000030342",
                    "term": "Genetic Diseases, Inborn"
                },
                {
                    "id": "D000017443",
                    "term": "Skin Diseases, Eczematous"
                },
                {
                    "id": "D000006969",
                    "term": "Hypersensitivity, Immediate"
                },
                {
                    "id": "D000006967",
                    "term": "Hypersensitivity"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M7071",
                    "name": "Dermatitis, Atopic",
                    "asFound": "Atopic Dermatitis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7067",
                    "name": "Dermatitis",
                    "asFound": "Dermatitis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7655",
                    "name": "Eczema",
                    "asFound": "Atopic Dermatitis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M15674",
                    "name": "Skin Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M15676",
                    "name": "Skin Diseases, Genetic",
                    "relevance": "LOW"
                },
                {
                    "id": "M23686",
                    "name": "Genetic Diseases, Inborn",
                    "relevance": "LOW"
                },
                {
                    "id": "M19712",
                    "name": "Skin Diseases, Eczematous",
                    "relevance": "LOW"
                },
                {
                    "id": "M10018",
                    "name": "Hypersensitivity",
                    "relevance": "LOW"
                },
                {
                    "id": "M10020",
                    "name": "Hypersensitivity, Immediate",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        }
    },
    "hasResults": false
}